Claims that pharmacy benefit managers (PBMs) and the rebates they negotiate from drug companies are to blame for…
This week Novo Nordisk – one of the largest drug companies manufacturing GLP-1 weight-loss medications – will testify…
A new Business Group on Health survey of employers uncovered a truth: soaring demand for GLP-1 weight-loss drugs…
In an effort to lower health costs, the U.S. Patent and Trademark Office (USPTO) has proposed new regulations…
As a new year begins, many Americans – including Members of Congress – are rightly asking why drug…
As 2024 begins, it brings an all-too-familiar tradition from big drug companies: a tidal wave of price hikes…
New research out today from CAPD, conducted by Hart Research Associates, shows how strongly union households value their…
GOP candidates will soon take the stage for one of the biggest political moments of the year: the…
It’s hard to miss the recent headlines about new weight-loss drugs like Ozempic and Wegovy. Called GLP-1s, these…
Over the last twenty years, new medications have dramatically changed the fight against HIV/AIDS. These medications – called…
